Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

antimicrobial sensitivity testing agar diffusion method or kirby ..., Lecture notes of Pharmacokinetics

In the Agar Diffusion Method, also known as the Kirby-Bauer Test, a Petri plate containing an agar medium is inoculated, "seeded", uniformly over the entire ...

Typology: Lecture notes

2021/2022

Uploaded on 09/12/2022

paperback
paperback 🇺🇸

4.8

(12)

264 documents

1 / 8

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Exercise 24-B
ANTIMICROBIAL SENSITIVITY TESTING
AGAR DIFFUSION METHOD OR KIRBY-BAUER TEST
Introduction
Antimicrobial drugs are a class of chemotherapeutic agents used in the treatment of infectious
diseases. They can generally be divided into four groups as follows: 1) synthetic antimicrobial drugs,
2) antibiotics (substances produced at least originally by living organisms and used to control bacteria),
3) antiviral drugs, and 4) anti-protozoan and anti-helminthic drugs.
In clinical situations, once the causative agent of a specific disease has been isolated, the physician
needs to know as quickly as possible, which antimicrobial drug will be most effective against it. The
use of filter-paper disks impregnated with antimicrobial agents is one method that can readily provide
this information.
Antimicrobial impregnated disks were introduced in the late 1940’s when penicillin came into
widespread use. Since then, a multitude of new antimicrobial drugs has been discovered, and much
experimentation has been done to develop a method to accurately and reliably test their effectiveness.
In the Agar Diffusion Method, also known as the Kirby-Bauer Test, a Petri plate containing an agar
medium is inoculated, "seeded", uniformly over the entire surface with a standardized amount of a test
culture. The organism type being tested may be mixed with a small amount of liquefied agar and poured
over the agar surface, or may be streaked onto the surface using a cotton swab dipped in broth culture.
Next, filter paper disks impregnated with known concentrations of chemotherapeutic agents are placed
on the solidified agar surface. During incubation, the antimicrobial agents, or drugs, diffuse from the
disks into the agar, and inhibit the growth of sensitive organisms in a zone immediately surrounding
each disk (the zone of inhibition). Since the concentration of each drug decreases progressively the
farther it diffuses from the disk, the concentration at the outside edge of the zone of inhibition represents
the minimum inhibitory concentration (MIC) for that drug. The diameter of the zone of inhibition
may be measured with a ruler; however, a wider zone does not necessarily indicate greater antimicrobial
activity. The diameter of the zone of inhibition is influenced by the rate of diffusion for the
antimicrobial agent being tested, the depth and type of agar medium being used, the incubation
conditions, and many other factors. For this reason, Agar Diffusion tests are always performed under
standardized conditions, and results are evaluated using predetermined tables.
For the Kirby-Bauer method as sanctioned by the FDA and the subcommittee on Antimicrobial
Susceptibility Testing of the National Committee for Clinical Laboratory Standards, the recommended
medium is Mueller-Hinton Agar, pH adjusted to 7.2 - 7.4 and poured to a uniform thickness of 4 mm
in Petri plates. For certain fastidious microorganisms, 5% defibrinated animal blood (sheep, horse, or
other) may be added. Inoculation is made from broth cultures with a specified turbidity. High potency
disks are placed on the agar surface, and the plates are incubated for 16 - 18 hours at 37o C. Zones of
inhibition are measured to the nearest millimeter, and the results are evaluated.
The minimum inhibitory concentration (MIC) as described above is one example of a breakpoint,
i.e., a discriminatory antimicrobial concentration used in the interpretation of the results obtained
during susceptibility testing to define isolates as susceptible (sensitive), intermediate or resistant.
pf3
pf4
pf5
pf8

Partial preview of the text

Download antimicrobial sensitivity testing agar diffusion method or kirby ... and more Lecture notes Pharmacokinetics in PDF only on Docsity!

Exercise 24-B

ANTIMICROBIAL SENSITIVITY TESTING

AGAR DIFFUSION METHOD OR KIRBY-BAUER TEST

Introduction Antimicrobial drugs are a class of chemotherapeutic agents used in the treatment of infectious diseases. They can generally be divided into four groups as follows: 1) synthetic antimicrobial drugs ,

  1. antibiotics (substances produced at least originally by living organisms and used to control bacteria),
  2. antiviral drugs , and 4) anti-protozoan and anti-helminthic drugs. In clinical situations, once the causative agent of a specific disease has been isolated, the physician needs to know as quickly as possible, which antimicrobial drug will be most effective against it. The use of filter-paper disks impregnated with antimicrobial agents is one method that can readily provide this information. Antimicrobial impregnated disks were introduced in the late 1940’s when penicillin came into widespread use. Since then, a multitude of new antimicrobial drugs has been discovered, and much experimentation has been done to develop a method to accurately and reliably test their effectiveness. In the Agar Diffusion Method , also known as the Kirby-Bauer Test , a Petri plate containing an agar medium is inoculated, "seeded", uniformly over the entire surface with a standardized amount of a test culture. The organism type being tested may be mixed with a small amount of liquefied agar and poured over the agar surface, or may be streaked onto the surface using a cotton swab dipped in broth culture. Next, filter paper disks impregnated with known concentrations of chemotherapeutic agents are placed on the solidified agar surface. During incubation, the antimicrobial agents, or drugs, diffuse from the disks into the agar, and inhibit the growth of sensitive organisms in a zone immediately surrounding each disk (the zone of inhibition ). Since the concentration of each drug decreases progressively the farther it diffuses from the disk, the concentration at the outside edge of the zone of inhibition represents the minimum inhibitory concentration (MIC) for that drug. The diameter of the zone of inhibition may be measured with a ruler; however, a wider zone does not necessarily indicate greater antimicrobial activity. The diameter of the zone of inhibition is influenced by the rate of diffusion for the antimicrobial agent being tested, the depth and type of agar medium being used, the incubation conditions, and many other factors. For this reason, Agar Diffusion tests are always performed under standardized conditions , and results are evaluated using predetermined tables. For the Kirby-Bauer method as sanctioned by the FDA and the subcommittee on Antimicrobial Susceptibility Testing of the National Committee for Clinical Laboratory Standards, the recommended medium is Mueller-Hinton Agar , pH adjusted to 7.2 - 7.4 and poured to a uniform thickness of 4 mm in Petri plates. For certain fastidious microorganisms, 5% defibrinated animal blood (sheep, horse, or other) may be added. Inoculation is made from broth cultures with a specified turbidity. High potency disks are placed on the agar surface, and the plates are incubated for 16 - 18 hours at 37 o C. Zones of inhibition are measured to the nearest millimeter, and the results are evaluated. The minimum inhibitory concentration (MIC) as described above is one example of a breakpoint , i.e., a discriminatory antimicrobial concentration used in the interpretation of the results obtained during susceptibility testing to define isolates as susceptible (sensitive), intermediate or resistant.

Data used to generate this type of breakpoint are obtained from multiple in vitro MIC tests. Bacterial strains are designated as “wild type” if they show no resistance to the drug being examined, or drugs with the same mechanism/site of action. Clinical breakpoints refer to those concentrations (MICs) that separate strains where there is a high likelihood of treatment success from those where treatment is more likely to fail, and are based on results obtained during multiple clinical trials. A third use of the term breakpoint can be applied to the therapeutic dose , i.e., the concentration of an antimicrobial drug expected to yield clinical control of a particular pathogen within the human body. This must integrate drug potency against specific populations of potential pathogens with the pharmacokinetics ( PK )/ pharmacodynamics ( PD ) of antimicrobial agents (what happens to drugs inside the body due to metabolic processes). The accurate determination of therapeutic dose must take into account in vivo complexities such as dosing schedule, the site of infection, likely PK/PD of the drug within a specific individual, adequacy of host defenses and a range of other factors. Typically PK/PD breakpoints are determined using data generated in animal models and then extrapolated to humans using mathematical or statistical techniques. Breakpoints must be continuously monitored and modified because mutations and gene transfer mechanisms allow potential pathogens to survive the selective pressures exerted by human application of antimicrobial agents (evolution happens). A list of organizations involved in setting breakpoints can be found at: http://cmr.asm.org/content/20/3/391/T1.expansion.html Note – Antimicrobial drugs are sometimes used in the identification of microorganisms, since certain species are more or less susceptible to particular drugs. For example, Streptococcus pyogenes is sensitive to Bacitracin (0.04 units per disc) while other pathogenic streptococci are not. In addition, certain drugs may be added to media to inhibit the growth of unwanted contaminants or to insure that the only cells growing are carrying specific "marker" genes. Procedure:

  1. Select the organism type you are to work with from the following table: Organism types: Student #'s: Staphylococcus aureus 1, 7, 13, 17, 21, 25, Escherichia coli 2, 8, 14, 18, 22, 26, Proteus mirabilis 3, 9, 15, 19, 23, 27, Pseudomonas aeruginosa 4, 10, 16, 20, 24, 28, Bacillus cereus 5, 11, Serratia marcescens 6, 12,
  2. Obtain a plate of Mueller-Hinton agar and label it with the name of the culture being tested (as indicated in the table above).
  3. Inoculate the surface of the medium using a sterile cotton swab that has been dipped into the appropriate broth culture. Be careful to squeeze the excess fluid from the swab by pressing and rotating it against the inside of the tube above the fluid level. Cover the entire surface of the agar evenly by swabbing in 3 directions. Make a final sweep around the inner rim of the plate to insure coverage near the edge. Do not create a “checker-board” pattern.
  4. Place the inoculated plate agar-side down on a clean surface , remove the plate lid and place the automatic disc dispenser over the plate.

ANTIMICROBIC ZONE OF INHIBITION EVALUATION

Kirby-Bauer Method (Significance of Zone Diameters When Using High Potency Antimicrobial Sensitivity Disks) Antimicrobial Disk R I S Agent Potency Resistant Intermediate Sensitive mm. mm. mm.


Amikacin 10 mcg <12 12 - 13 > Ampicillin Gram-negative 10 mcg <12 12 - 13 > and enterococci Staphylococci & pcn G 10 mcg <21 21 - 28 > susceptibles Bacitracin 10 units < 9 9 - 12 > Carbenicillin Proteus sp. and E. coli 50 mcg <18 18 - 22 > Pseudomonas aeruginosa 50 mcg <13 13 - 14 > Cephalothin For cephaloglycin only 30 mcg <15 > For other cephalosporins 30 mcg <15 15 - 17 > Chloramphenicol 30 mcg <13 13 - 17 > Clindamycin 2 mcg <15 15 - 16 > Colistin 1 0 mcg < 9 9 - 10 > Erythromycin 15 mcg <14 14 - 17 > Gentamicin for P. aeruginosa 10 mcg <13 > Kanamycin 30 mcg <14 14 - 17 > Lincomycin (Clindamycin) 2 mcg <17 17 - 20 > Methicillin (Penicillinase-resistant 5 mcg <10 10 - 13 > penicillin class) Nafcillin 1 mcg <11 11 - 12 > Nalidixic Acid 30 mcg <14 14 - 18 > Neomycin 30 mcg <13 13 - 16 > Nitrofurantoin 300 mcg <15 15 - 16 > Novobiocin 30 mcg <18 18 - 21 > Oleandomycin 15 mcg <21 18 - 21 > Oxolinic Acid 2 mcg <11 > Penicillin G for staphylococci 10 units <21 21 - 28 > For other organisms 10 units <12 12 - 21 > Polymyxin B 300 units < 9 9 - 11 > Rifampin for S. pneumoniae 5 mcg <16 17 - 18 > For other organisms 5 mcg <16 17 - 19 > Streptomycin 10 mcg <12 12 - 14 > Tetracycline 30 mcg <15 15 - 18 >1 8 Tobramycin 10 mcg <12 12 - 13 > Triple Sulfa 350 mcg <12 13 - 16 > Vancomycin 30 mcg <10 10 - 11 >


________________________________________________________________________________

AM- 10 Ampicillin E- 15 Erythromycin OA- 2 Oxolinic Acid AN- 10 Amikacin FM- 300 Nitrofurantoin OL- 15 Oleandomycin B- 10 Bacitracin GM- 10 Gentamycin P- 10 Penicillin G C- 30 Chloramphenicol K- 30 Kanamycin PB- 300 Polymyxin B CB- 50 Carbenicillin L- 2 Lincomycin RA- 5 Rifampin CB- 100 Carbenicillin N- 30 Neomycin S- 10 Streptomycin CC- 2 Clindamycin NA- 30 Nalidixic Acid SSS- 25 Triple Sulfonamides CF- 30 Cephalothin NB- 30 Novobiocin Te- 30 Tetracycline CL- 10 Colistin NF- 1 Nafcillin Va- 30 Vancomycin DP- 5 Methicillin NN- 10 Tobramycin



A Aureomycin GM Gentamycin PB Polymyxin B Am Ampicillin K Kanamycin RA Rifampin An Amikacin L Lincomycin S Streptomycin B Bacitracin LR Cephaloridine SD Sufadiazine C Chloromycetin ME Methicillin SSS Triple Sulfa CB Carbenicillin N Neomycin SM Sulfamerazine CC Clindamycin NA Nalidixic Acid ST Sulfathiazole CL Colistin NB Novobiocin T Terramycin CR Cephalothin NF Nafcillin TE Tetracycline CX Cloxacillin OA Oxolinic Acid TM Tobramycin E Erythromycin OL Oleandomycin V Viomycin FD Nitrofurantoin P Penicillin G VA Vancomycin


Name ________________________________ Lab Section ________________ WORKSHEET Exercise 24B Antimicrobial Sensitivity Testing Goals : ___________________________________________________________________________



Materials & Methods: The Kirby-Bauer antimicrobial sensitivity procedure was followed. Organism type used: ________________________________________________________________ Medium used: _____________________________________________________________________ Incubation temperature: ________________ Duration of incubation: __________________________ Data & Results: Antimicrobial Agent Zone of Inhibition R, I, or S? Conclusions:








NOTES, OBSERVATIONS & ADDITIONAL INFORMATION